PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+2.87%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.56B
AUM Growth
+$2.56B
(-11%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-11.68%
Top 10 Holdings %
Top 10 Hldgs %
59.29%
Holding
159
New
16
Increased
42
Reduced
54
Closed
15
Top Buys
| 1 |
Cameco
CCJ
|
$74.8M |
| 2 |
Pinduoduo
PDD
|
$38.6M |
| 3 |
Mobileye
MBLY
|
$28M |
| 4 |
Valaris
VAL
|
$15.7M |
| 5 |
Carlisle Companies
CSL
|
$10.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$63.9M |
| 2 |
Gilead Sciences
GILD
|
$53.6M |
| 3 |
Suncor Energy
SU
|
$46.6M |
| 4 |
Scorpio Tankers
STNG
|
$34.4M |
| 5 |
ZTO Express
ZTO
|
$32.9M |
Sector Composition
| 1 | Consumer Discretionary | 18.32% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 16.93% |
| 4 | Energy | 15.13% |
| 5 | Financials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
51
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $4.93M | 0.19% |
+222,222
| New | +$4.93M |
|
52
Cogent Biosciences
COGT
$1.83B
| $4.64M | 0.18% |
475,837
-1,243
| -0.3% | -$12.1K |
|
53
Gossamer Bio
GOSS
$587M
| $4.46M | 0.17% |
5,357,778
+2,994,608
| +127% | +$2.49M |
|
|
INBX
54
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.2M | 0.16% |
229,036
| – | – |
|
|
NSTG
55
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.93M | 0.15% |
2,285,137
+1,168,745
| +105% | +$2.01M |
|
56
AC Immune
ACIU
$227M
| $3.77M | 0.15% |
1,322,462
| – | – |
|
57
Arcus Biosciences
RCUS
$1.24B
| $3.67M | 0.14% |
204,398
-28,214
| -12% | -$506K |
|
58
Sagimet Biosciences
SGMT
$239M
| $3.38M | 0.13% |
+383,913
| New | +$3.38M |
|
59
Merus
MRUS
$5.04B
| $3.35M | 0.13% |
142,029
-8,209
| -5% | -$194K |
|
60
Allegion
ALLE
$14.4B
| $3.28M | 0.13% |
+31,507
| New | +$3.28M |
|
61
Esperion Therapeutics
ESPR
$490M
| $3.13M | 0.12% |
3,189,517
-280,117
| -8% | -$275K |
|
62
Match Group
MTCH
$9.04B
| $3.12M | 0.12% |
79,760
-28,066
| -26% | -$1.1M |
|
63
Immatics
IMTX
$662M
| $3.11M | 0.12% |
268,211
| – | – |
|
64
Bio-Rad Laboratories Class A
BIO
$7.8B
| $3.1M | 0.12% |
8,636
| – | – |
|
65
HUTCHMED
HCM
$2.62B
| $3.08M | 0.12% |
182,052
| – | – |
|
66
Amazon
AMZN
$2.41T
| $2.87M | 0.11% |
22,613
+15,315
| +210% | +$1.95M |
|
67
Vera Therapeutics
VERA
$1.47B
| $2.75M | 0.11% |
200,302
-9,398
| -4% | -$129K |
|
68
Netflix
NFLX
$521B
| $2.71M | 0.11% |
7,179
-7,543
| -51% | -$2.85M |
|
69
Structure Therapeutics
GPCR
$1.14B
| $2.65M | 0.1% |
52,461
+37,461
| +250% | +$1.89M |
|
70
Wave Life Sciences
WVE
$1.27B
| $2.62M | 0.1% |
455,331
| – | – |
|
71
Arrowhead Research
ARWR
$3.84B
| $2.61M | 0.1% |
97,168
| – | – |
|
72
Zymeworks
ZYME
$1.07B
| $2.6M | 0.1% |
409,839
| – | – |
|
73
Oracle
ORCL
$628B
| $2.56M | 0.1% |
24,143
+6,021
| +33% | +$638K |
|
|
CNTG
74
DELISTED
Centogene N.V. Common Shares
CNTG
| $2.52M | 0.1% |
2,377,150
| – | – |
|
75
CureVac
CVAC
$1.21B
| $2.48M | 0.1% |
363,280
+137,146
| +61% | +$937K |
|